Fairvalue-Calculator Fairvalue-Calculator
EN DE

T&L Co (340570) Fair Value & Analysis

Healthcare · KR · Market cap 469B KRW

Price53,200 KRW
Fair Value97,873 KRW
Upside+84.0%
Quality95/100
Evidence: High Range 73,003 KRW – 211,699 KRW

Fair value as of: Jun 25, 2026

Analysis

T&L Co (340570) currently trades at 53,200 KRW, while our model-based Fair Value estimate is 97,873 KRW — implying the stock looks roughly 84.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is T&L Co (340570) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 97,873 KRW versus a price of 53,200 KRW — about +84% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 340570?
Our 21-model fair value for T&L Co is 97,873 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 53,200 KRW.
What is the quality score of 340570?
T&L Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.